ECL

Assess Ecolab's Fundamentals Before Making a Purchase

Ecolab logged a 2.6% change during today's afternoon session, and is now trading at a price of $175.55 per share. On average, analysts give it a target price of $195.5.

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The large-cap company is based in the United States. Ecolab currently returns an annual dividend yield of 1.2%.

Make Sure to Consider the Following Before Buying Ecolab:

  • Ecolab has moved 31.0% over the last year.

  • ECL has a forward P/E ratio of 29.0 based on its EPS guidance of 6.05.

  • Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of -2.8%.

  • The company has a price to earnings growth (PEG) ratio of 2.18.

  • Its Price to Book (P/B) ratio is 7.48

Ecolab Has Irregular Cash Flows

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 2,067,500 741,000 1,326,500 23.33
2022 1,788,400 712,800 1,075,600 -24.19
2021 2,061,900 643,000 1,418,900 3.48
2020 1,860,200 489,000 1,371,200 -18.84
2019 2,420,700 731,300 1,689,400 12.7
2018 2,277,700 778,700 1,499,000

Ecolab's free cash flows have a decent average of $1.4 Billion over the last 6 years, but they are highly variable since their coefficient of variability is 3467.5%. The compounded average growth rate over this period is -2.0%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS